Supporting Cross-Benefit Management of Infused Drugs

home / peer-exchange / supporting-cross-benefit-management-of-infused-drugs

Optimizing the clinical and financial aspects of disease management when covering an infused drug product under the pharmacy and medical benefit.

Episodes

Choosing Drug-related Routes of Administration

October 12th 2020EP. 1: Choosing Drug-related Routes of Administration

Routes of Administration: Adherence and Persistence

October 12th 2020EP. 2: Routes of Administration: Adherence and Persistence

Alignment of Incentives: Optimizing Routes of Administration

October 12th 2020EP. 3: Alignment of Incentives: Optimizing Routes of Administration

Cost Considerations for Self- vs HCP-administered Agents

October 12th 2020EP. 4: Cost Considerations for Self- vs HCP-administered Agents

Preferred Site of Care and Coverage for Infusions

October 12th 2020EP. 5: Preferred Site of Care and Coverage for Infusions

Utilization Management Through Medical and Pharmacy Benefit

October 12th 2020EP. 6: Utilization Management Through Medical and Pharmacy Benefit

Cost Dispersion of Infused Drugs

October 12th 2020EP. 7: Cost Dispersion of Infused Drugs

Self-injectables: Emerging Agents for the Management of MS

October 12th 2020EP. 8: Self-injectables: Emerging Agents for the Management of MS

Evolving Management of Drug Spending Monitoring

October 12th 2020EP. 9: Evolving Management of Drug Spending Monitoring

Transparency Among Medical and Pharmacy Benefits

October 12th 2020EP. 10: Transparency Among Medical and Pharmacy Benefits

Management of Drug Spending and Impact of COVID-19

October 12th 2020EP. 11: Management of Drug Spending and Impact of COVID-19

Future of Medical and Pharmacy Benefit Integration

October 12th 2020EP. 12: Future of Medical and Pharmacy Benefit Integration

Recent Content

FDA approval | Image Credit: © Olivier Le Moal-stock.adobe.com

FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis

COVID-19 illustration | Image Credit: Production Perig - stock.adobe.com

AJMC Studies Explore the Pandemic's Impact on Telehealth, Care Access, and Patient Experience

Health care costs - Valeri Luzina - stock.adobe.com

The Impact of Cost Sharing on High-Value Care

Semaglutide. | Image Credit: K KStock - stock.adobe.com

Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive

View More Recent Content

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions